Suchergebnisse - "Jäger, Roland"

PubPharm (34)

1

Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms

enthalten in: Haematologica | 2024

von Borsani, O. | Jäger, R. | Pietra, D. | +4

2

Effects of Tulp4 deficiency on murine embryonic development and adult phenotype

enthalten in: Microscopy research and technique | 2024

von Jäger, R. | Geyer, S. | Kavirayani, A. | +6

3

Effects of Tulp4 deficiency on murine embryonic development and adult phenotype

enthalten in: Microscopy Research and Technique | 2024

von Jäger, R. | Geyer, S. | Kavirayani, A. | +6

4

PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms

enthalten in: American journal of hematology | 2022

von Milosevic Feenstra, J. | Jäger, R. | Schischlik, F. | +14

5

PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms

enthalten in: American Journal of Hematology | 2022

von Milosevic Feenstra, J. | Jäger, R. | Schischlik, F. | +14

6

Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia

enthalten in: Haematologica | 2021

von Kornauth, C. | Herbaux, C. | Boidol, B. | +19

7

Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera

enthalten in: Blood | 2021

von Jäger, R. | Gisslinger, H. | Fuchs, E. | +10

CommentIn: Blood. 2021 Jan 21;137(3):291-293. - PMID 33475740

8

Multimodality imaging beyond CLEM : Showcases of combined in-vivo preclinical imaging and ex-vivo microscopy to detect murine mural vascular lesions

enthalten in: Methods in cell biology | 2021

von Keuenhof, K. | Heimel, P. | Zopf, L. | +15

9

Sleep Facilitates Problem Solving With No Additional Gain Through Targeted Memory Reactivation

enthalten in: Frontiers in behavioral neuroscience | 2021

von Beijamini, F. | Valentin, A. | Jäger, R. | +2

10

Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis

enthalten in: Cancers | 2020

von Geissler, K. | Gisslinger, B. | Jäger, E. | +9